Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update

Beyond Air, Inc. (NASDAQ:XAIR) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 966,700 shares, a decrease of 16.7% from the December 31st total of 1,160,000 shares. Based on an average trading volume of 1,240,000 shares, the short-interest ratio is presently 0.8 days.

Institutional Trading of Beyond Air

Large investors have recently added to or reduced their stakes in the company. Soros Fund Management LLC acquired a new stake in shares of Beyond Air in the third quarter worth $573,000. Baldwin Wealth Partners LLC MA boosted its holdings in Beyond Air by 721.3% in the fourth quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock valued at $110,000 after purchasing an additional 270,500 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in Beyond Air during the 2nd quarter worth about $47,000. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Beyond Air Trading Up 0.8 %

Shares of NASDAQ:XAIR opened at $0.38 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 5.76 and a quick ratio of 5.38. The firm has a market capitalization of $27.66 million, a P/E ratio of -0.27 and a beta of -0.17. The business’s 50-day moving average is $0.44 and its 200 day moving average is $0.45. Beyond Air has a 1 year low of $0.30 and a 1 year high of $2.17.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.02. Beyond Air had a negative net margin of 2,369.17% and a negative return on equity of 227.29%. The firm had revenue of $0.80 million for the quarter, compared to the consensus estimate of $1.19 million. During the same quarter in the prior year, the company posted ($0.51) earnings per share. On average, research analysts predict that Beyond Air will post -0.78 earnings per share for the current fiscal year.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.